During the past decade, RoMed Klinikum Rosenheim conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RoMed Klinikum Rosenheim" #1 sponsor was "C. R. Bard" with 4 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Shockwave Medical, Inc." with 2 trials sponsored, "Spectranetics Corporation" with 2 trials sponsored and "480 Biomedical" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RoMed Klinikum Rosenheim" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "RoMed Klinikum Rosenheim" are "Peripheral Arterial Disease" (8 trials), "Peripheral Artery Disease" (5 trials), "Breast Cancer" (4 trials), "Atherosclerosis" (3 trials) and "Arteriosclerosis" (2 trials). Many other conditions were trialed in "RoMed Klinikum Rosenheim" in a lesser frequency.

Most popular intervention types in "RoMed Klinikum Rosenheim" are "Device" (18 trials), "Drug" (16 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "014 Drug Coated Balloon" (1 trials) and "480 Biomedical Bioresorbable Scaffold System" (1 trials). Other intervention names were less common.

The vast majority of trials in "RoMed Klinikum Rosenheim" are 32 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "RoMed Klinikum Rosenheim". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in RoMed Klinikum Rosenheim, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in RoMed Klinikum Rosenheim, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".